ReleaseWire Connect

Due to the cyclic nature of the industry, cement prices show large fluctuations. The prices tend to increase during the periods of high demand growth & high capacity utilization, and witness a downturn movement if the industry sees low capacity utilization. According to a recent report by RNCOS “Indian Cement Industry Outlook 2016”, the industry is witnessing serious downturn in cement prices since the mid of 2012-13. Due to a slowing economy, the construction activities have declined, impacting demand of cement, which has resulted in reduction of prices as supply surpassed demand.

With the growing acceptance of medical tourism, people who need hair transplant, hair loss treatment and restoration are considering treatment abroad as a low-cost option. Since 2005, the number of tourists visiting Turkey for hair transplant has been increasing at a fast pace. In the recent years, Turkey has emerged as a prominent destination for hair transplant, highlights RNCOS in its recent report “Turkey Medical Tourism Outlook 2017”.

The injectable drug market across UK is growing owing to the technological up gradation and robust investment, which in a way offer immense opportunity for injectables to emerge in market. Moreover, increasing prevalence of chronic diseases including diabetes is also driving the injectable business. The diverse product portfolios offered by key market players even boost the growth of injectables. Meanwhile, a lot of innovation in drug delivery system has been done across the country so as to expand opportunities in injectable segment.

Mexico stands number eight in the list of top global footwear manufacturers. World renowned for its traditional expertise in footwear manufacturing, Mexico has grown leaps and bounds in innovative technological know-how, foreign trade and domestic consumption of indigenous footwear. Demographic dividend is the major driver for rising domestic consumption of footwear in Mexico. RNCOS latest research reveals that footwear sales in Mexico shall grow at a CAGR of around 6% during 2012-2017 driven by growing middle class population which accounts for approx. 39% of the country’s total population.

The new report by RNCOS “Global Electric Vehicles Market Outlook 2020”, highlights the prospects of fuel cell electric vehicle in the near future. Fuel cell electric vehicles (FCEVs) are emerging as the new concept electric vehicles due to its numerous advantages over other electric vehicles. Automakers around the world are taking strong initiatives to make steady progress in reducing the cost and increasing the performance and durability of fuel cell propulsion systems.

As per the new research report by RNCOS, “Indian Medical Device Market Outlook to 2017”, market for medical devices in India is going through an exciting phase. Boosted by various factors like a rapidly expanding healthcare infrastructure and rising demand of high quality medical devices by medical tourists, the market is expected to grow at a high double digit growth rate to reach around US$ 11 Billion by 2017.

US dominate the telemedicine market and increasing ageing population throughout is driving this market. Telemedicine business in the country has become profitable compared to other countries because of advancements in telemedicine solutions delivering effective care. Besides, advancement in technology, slashing costs and government interventions also support the growth of telehealth services and has been proved beneficial for rural patients.

Europe is fast emerging as the hub for miRNA based research and has accounted for almost 30% of the miRNA market generated in the year 2012. This market is expected to grow at a CAGR of 19.5% till 2018. Most of the ongoing or completed studies in Europe are based on various types of cancer, with main focus on Melanoma and Breast Cancer followed closely by leukemia, renal and ovarian cancer. Other major areas of interest in Europe include Obesity, Diabetes and Multiple Sclerosis. The major institutes responsible for carrying out research include Assistance Publique Hopitaux De Marseille and Centre Hospitalier Universitaire de Nice in France, Ruhr University of Bochum in Germany and Rigshospitalet in Denmark. With such a fast paced growth, Europe is emerging as an area of interest for miRNA players.

India’s IVF market is poised to reach INR14.2 Billion by the end of 2013. The very market is anticipated to register a double digit CAGR over the 5 year period spanning from 2013 to 2018. In the coming years, many new IVF clinics are likely to start operating in India. Furthermore, on the technological front, some novel and advanced technologies are also under development, which will find substantial use in the field of IVF. These factors will significantly impact the growth of IVF market in India in the near future.

The combined contribution of various factors such as increasing support from the government, rise in the expenditure on healthcare, and growth in the investments made by the private players will result in a RUB 1.5 Trillion pharmaceutical market in Russia by 2017. Similar to earlier years, the commercial drugs segment was estimated to have occupied the largest market share in 2012. Besides, the state drug segment is continuously declining and losing its share to the commercial segment.